🎁 Black Friday: up to 50% off of annual plans
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
63.34
-1.54 (-2.37%)
At close: Nov 20, 2026, 4:00 PM EST
63.65
+0.31 (0.49%)
After-hours: Nov 20, 2026, 7:56 PM EST

TG Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
429.3879.15179.8992.93102.3298.89
Short-Term Investments
75.362.82131.11124.5859.3715.88
Cash & Short-Term Investments
504.67141.97311217.51161.68314.76
Cash Growth
283.54%-54.35%42.98%34.53%-48.63%-48.01%
Accounts Receivable
416.82305.63129.1951.09-1.39
Receivables
416.82305.63129.1951.09-1.39
Inventory
194.32125.59110.4639.82--
Other Current Assets
55.6457.5815.729.526.614.81
Total Current Assets
1,171630.76566.36317.94168.27330.97
Property, Plant & Equipment
6.836.287.158.059.29.23
Long-Term Investments
56.0459.140.81-12.435.53
Goodwill
----0.80.8
Long-Term Deferred Tax Assets
333.38348----
Long-Term Deferred Charges
----1.631.84
Other Long-Term Assets
24.5619.083.373.591.271.26
Total Assets
1,5921,063577.69329.59193.57379.63

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
81.0647.4137.429.2742.0250.89
Accrued Expenses
79.641.0515.1912.178.4310.17
Current Portion of Long-Term Debt
-0.690.660.360.241.34
Current Portion of Leases
1.841.041.161.451.581.44
Current Unearned Revenue
26.121.2311.410.15-0.2
Other Current Liabilities
71.9242.3424.8710.320.931.35
Total Current Liabilities
260.53153.7690.6853.7253.265.38
Long-Term Debt
745.63245.65244.43100.1271.1466.79
Long-Term Leases
6.97.028.139.2310.349.85
Long-Term Unearned Revenue
7.078.8112.096.020.310.46
Total Liabilities
1,020415.23355.33169.09134.99142.48

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.160.160.160.150.150.14
Additional Paid-In Capital
1,8711,8301,7601,7131,5861,566
Retained Earnings
-998.99-1,082-1,529-1,553-1,527-1,329
Treasury Stock
-300.22-100.23-8.99-0.23-0.23-0.23
Shareholders' Equity
572.13648.02222.36160.558.59237.15
Total Liabilities & Equity
1,5921,063577.69329.59193.57379.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
754.37254.4254.38111.1583.379.41
Net Cash (Debt)
-249.7-112.4356.62106.3678.38235.36
Net Cash Growth
---46.76%35.70%-66.70%-58.16%
Net Cash Per Share
-1.58-0.700.350.720.581.78
Filing Date Shares Outstanding
140.1147.68145.23144.78137.63130.79
Total Common Shares Outstanding
140.11143.29143.99141.79137.65131.22
Working Capital
910.92477475.68264.22115.07265.58
Book Value Per Share
4.084.521.541.130.431.81
Tangible Book Value
572.13648.02222.36160.557.79236.35
Tangible Book Value Per Share
4.084.521.541.130.421.80
SEC Filings: 10-K · 10-Q